Director, Biostatistics FSP

Cytel•United States,

About The Position

The Medical Affairs & HTA Statistician provides strategic and technical statistical expertise to support evidence generation across the product lifecycle, with emphasis on Medical Affairs, real-world evidence, comparative effectiveness, and Health Technology Assessment. The role translates clinical, observational, and real-world data into scientifically robust evidence relevant to patients, clinicians, payers, and healthcare systems. It combines statistical methodology, scientific judgment, strategic thinking, and cross-functional communication.

Requirements

  • Senior-level statistical or biostatistical experience within the pharmaceutical or healthcare environment.
  • Demonstrated experience delivering Medical Affairs and/or HTA statistical work packages.
  • Broad methodological expertise spanning clinical, observational, and real-world data.
  • Strong experience in one or more of: RWE, epidemiological research, comparative effectiveness, indirect treatment comparisons, synthetic controls, HTA/HEOR, or Phase IV research.
  • Strong understanding of evidence-generation strategies across the pharmaceutical product lifecycle.
  • Ability to assess data quality, methodological limitations, bias, uncertainty, and applicability of evidence.
  • Experience communicating statistical findings in publications, scientific discussions, and/or evidence packages.
  • Strong scientific judgment, strategic thinking, and stakeholder-management skills.
  • Ability to collaborate across multidisciplinary and geographically distributed teams.

Responsibilities

  • Provide statistical leadership for Medical Affairs and HTA evidence-generation activities.
  • Support development of evidence strategies addressing clinical, patient, payer, and healthcare-system questions.
  • Design and analyse observational and real-world evidence studies.
  • Apply epidemiological and statistical methodologies to real-world and clinical data.
  • Conduct comparative-effectiveness assessments and indirect treatment comparisons.
  • Support synthetic-control approaches, Phase IV studies, and other post-approval evidence-generation activities.
  • Apply appropriate HTA/HEOR methodologies and contribute statistical expertise to evidence packages supporting access and reimbursement decisions.
  • Assess data relevance and quality, quantify and communicate uncertainty, and strengthen the methodological credibility of HTA submissions and scientific discussions.
  • Interpret clinical and observational evidence and translate complex analyses into clear scientific conclusions.
  • Support publications, congress activities, and other scientific communications where required.
  • Apply modern analytical methods, including machine learning, where scientifically appropriate.
  • Collaborate with Development Statistics, Epidemiology, Real-World Evidence teams, Medical functions, and external scientific partners.
  • Communicate statistical concepts and findings effectively to cross-functional and external stakeholders.
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service